We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cabozantinib in Men With Castration-Resistant Prostate Cancer

This study has been terminated.
(Closed 2017 for low accrual. Last data for primary outcome on 02Feb2015.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01703065
First Posted: October 10, 2012
Last Update Posted: December 5, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Prostate Cancer Foundation
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Celestia Higano, University of Washington
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 18, 2015
  Primary Completion Date: February 2, 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: October 16, 2017